What question did this study set out to answer?

To evaluate the efficacy and survival outcomes associated with complementary Chinese herbal medicine therapy among patients diagnosed with cancer.

June 5, 2023Journal of the Chinese Medical AssociationOpen Access

To explore the effects of herbal medicine among cancer patients in Taiwan: A cohort study

View Full Paper

Ask AI

Bookmark

Authors

TLTsai-Feng LiNational Yang Ming Chiao Tung University IHI-Hsuan HwangCheng Hsin General Hospital CTCheng-Hung TsaiFeng Chia University

Discussion

Member takes

Implication

Cohort study reveals improved survival and lower recurrence across cancer patients receiving complementary herbal medicine, suggesting dose-dependent therapeutic benefits.

Key Points

To evaluate the efficacy and survival outcomes associated with complementary Chinese herbal medicine therapy among patients diagnosed with cancer.
Population-based cohort study utilizing data from Taiwan's National Health Insurance program for patients diagnosed with cancer between 2005 and 2015 (N = 5,707).
Patients were categorized into standard therapy alone (n = 4,797) or complementary Chinese herbal medicine (CHM) therapy (n = 910), with the CHM cohort stratified into low cumulative dosage (LCD; n = 449), medium cumulative dosage (MCD; n = 374), and high cumulative dosage (HCD; n = 87) subgroups.
Mortality risk was 0.83 in the LCD, 0.64 in the MCD, and 0.45 in the HCD subgroup, with corresponding 11-year overall survival times of 6.1 ± 0.2, 6.9 ± 0.2, and 8.2 ± 0.4 years.
Five-year cumulative recurrence rates were 39.2% (LCD), 31.5% (MCD), and 18.8% (HCD) versus 40.9% in the standard therapy group; 5-year metastasis rates were 39.5%, 32.8%, and 16.6% versus 32.8%, respectively.
The cumulative recurrence rates (for all cancers, lung, and liver cancers) and metastasis rates (for all cancers, colorectal, and breast cancers) were significantly lower in the HCD subgroup than in the standard therapy group (p < 0.05).

Cite This Study

Li et al. (2023) studied this question.

synapsesocial.com/papers/6a70463f2163a0a01bc47df9 https://doi.org/10.1097/jcma.0000000000000945

View Full Paper

Ask AI

Bookmark

Implication

Cohort study reveals improved survival and lower recurrence across cancer patients receiving complementary herbal medicine, suggesting dose-dependent therapeutic benefits.

To explore the effects of herbal medicine among cancer patients in Taiwan: A cohort study

Discussion

Member takes

Implication

Key Points

Cite This Study

To explore the effects of herbal medicine among cancer patients in Taiwan: A cohort study

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider